z-logo
open-access-imgOpen Access
AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis
Author(s) -
Ramoji Kosuru,
Yin Cai,
Vidya Kandula,
Dan Yan,
Chunyan Wang,
Hong Zheng,
Yalan Li,
Michael G. Irwin,
Sanjay Singh,
Zhengyuan Xia
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000489154
Subject(s) - pterostilbene , cardioprotection , ampk , medicine , oxidative stress , diabetes mellitus , streptozotocin , reperfusion injury , diabetic cardiomyopathy , endocrinology , lactate dehydrogenase , ischemia , pharmacology , protein kinase a , chemistry , kinase , resveratrol , heart failure , cardiomyopathy , biochemistry , enzyme
Pterostilbene (PT) exerts antidiabetic effects by decreasing blood glucose and modulating lipid metabolism and has been shown to attenuate myocardial ischemia-reperfusion (IR) injury in non-diabetic subjects. However, whether PT can protect against myocardial IR injury in diabetes is unknown. AMPK stimulation is indispensable in offering cardioprotection against myocardial IR injury in diabetes by limiting cardiac apoptosis. Thus, we hypothesized that PT may confer protection against myocardial IR injury in diabetes via AMPK activation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom